Navin Chaddha

“I partner with entrepreneurs who want to change the way people work, live, and play. I believe that company building is a marathon, not a sprint, and that crisis can be an opportunity for the bold.”

Navin leads Mayfield as Managing Director. Under his leadership, Mayfield has raised eight funds. He has been named a Young Global Leader by the World Economic Forum and has ranked on the Forbes Midas List of Top 100 Tech Investors fourteen times, including being named in the Top Five in 2020 and 2022. Navin’s investments have created over $120 billion in equity value and over 40,000 jobs.

During his venture capital career, Navin has invested in over 60 companies, of which 18 have gone public and 27 have been acquired. Navin was one of the earliest Silicon Valley investors to leverage the promise of tech in India.

Navin is an active philanthropist who supports education, diversity, equity, inclusion, and food scarcity groups.

As an entrepreneur, Navin has co-founded or led three startups including VXtreme: a streaming media platform, acquired by Microsoft to become Windows Media; Rivio/CPA.com: a SaaS provider for small businesses, and iBeam Broadcasting (NASDAQ:IBEM): a streaming media content delivery network. Navin holds an MS degree in electrical engineering from Stanford University and a B.Tech degree in electrical engineering from IIT Delhi, where he was honored with the distinguished IIT Alumni Award.

Arvind Gupta

“Speed wins battles, patience wins wars.”

Arvind Gupta focuses on investments in Human & Planetary Health, where his mission is to invest in science based companies that could change history. Ranging from reinventing our food system to stopping climate change to novel therapeutics, Arvind was the first investor in breakout companies such as Geltor, Synthex, Prime Roots, NotCo, Prellis, New Culture, DNA Lite, Catalog, Prellis and Memphis Meats.

As Founder of IndieBio, Arvind redefined the pace and possibilities of early stage biotech, investing in over 136 companies in five years, defining human and planetary health, and growing the IndieBio portfolio into billions of dollars in value. Under his leadership, IndieBio expanded to New York and grew to fifteen investment professionals with a world renowned adjunct partner board. He now serves as Venture Advisor at IndieBio.

Arvind is the author of Decoding the World: A Roadmap for the Questioner, published by Twelve Books, a division of the Hachette Publishing Group. He was honored with the F50 Global Award for Impact in HealthTech Innovation. He is a frequent speaker at TechCrunch Disrupt, Slush, TedX and Future FoodTech. His work has been profiled in global media outlets such as Bloomberg News, Forbes, The Guardian UK, Neo.life, Nikkei News, Rotman, The Times of India, and CGTN in China. Arvind has been a guest lecturer at UCSF, MIT and Harvard and is a judge at the annual BIO conference startup stadium.

Prior to founding IndieBio, Arvind was Design Director at IDEO in Shanghai where he earned numerous international design awards and presented his work at the San Francisco Museum of Modern Art. He was also a BASE jumper and big wall climber and now fights professional grappling.

Arvind received his B.S. in Genetic Engineering from UCSB. He holds 8 patents.

Arvind is married to an Icelander and has two daughters.

Ursheet Parikh

“Software remains the fastest way to build large companies for global impact, and combining software with the advances in engineering biology will create a whole new class of trillion dollar companies.”

Ursheet invests in Infrastructure Software and Human & Planetary Health.

His investments in the enterprise sector include Versa Networks (Security and SD-WAN), Qwiet (Application Security), Rancher Labs (Cloud Computing platform acquired by SUSE), CloudGenix (SD-WAN platform acquired by Palo Alto Networks) and Netsil (Application Observability platform acquired by Nutanix).

Ursheet’s investments in human & planetary health include Mammoth Biosciences (CRISPR), Mission Bio (Single Cell Sequencing, Oncology), Qventus (Healthcare AI), Endpoint Health (Precision Immunology), Mirvie (predict and prevent pregnancy complications for moms and babies), GraphWear (Continuous Non-invasive Glucose Monitoring), Chemix (AI-powered next gen EV battery technologies) and Foodsmart (reverse metabolic disease).

Prior to Mayfield, Ursheet had an operating career as a repeat entrepreneur and executive at Cisco and Microsoft. Ursheet was co-founder & CEO of StorSimple – the leading cloud-integrated storage company that was acquired by Microsoft in 2012.

Ursheet holds an MBA from the Wharton School and a Bachelors in Computer Science from the Indian Institute of Technology in Mumbai, from which he received the Young Alumni Achiever award in 2015.

Ursheet is passionate about accelerating healthcare innovation and transforming college education where his family foundation is focused.